retatrutide glp 1 PDB-101: Molecule of the Month: GLP-1 Receptor Agonists New GLP-1 obesity drug, retatrutide,

GLP-1s may additionally impact other physiological changes observed in the perimenopausal period, including vasomotor symptoms like hot flashes and night sweats, declines in bone health, and unhealthy changes in body composition (gains in fat mass and declines in muscle mass), but whether these impacts are beneficial or harmful for women's health remains unknown

Also supplied as a lyophilised vial, so it follows the same reconstitution workflow

It also limits fat-storing signals like excess glucagon

GLP-1 induces barrier protective expression in Brunners glands and regulates colonic inflammation

Weight loss surgery, or bariatric surgery, is also an option for some people with a need to lose weight